Search
for
Sort by
Research 271–300 of 1000+
- Dermatologic Adverse Events from Cancer Treatments
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- The Effect of Amniotic Fluid On Haıir Follicle Growth
- Hair Re-Pigmentation After Nilotinib
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Advances in dermatology research: A comprehensive literature review
- Nanotechnology in Dermatology
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Redefining hormone resistance in prostate cancer
- Nobiletin-loaded composite penetration enhancer vesicles restore the normal miRNA expression and the chief defence antioxidant levels in skin cancer
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Estimation of health utility values for alopecia areata
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Bioorthogonal Catalytic Microneedles Based on a Cytotoxic PEI Matrix for Synergistic Melanoma Therapy
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- Clinical evaluation and treatment response in Patients with non-scarring alopecia: A Prospective Study of 200 Cases
- Comparative investigation of immune-related biomarkers related to alopecia areata subtypes
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata